ArticleFrontiers in oncology2025

Transarterial chemoembolization with rivoceranib and camrelizumab for BCLC stage C hepatocellular carcinoma.

Rui Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.